A retrospective study exploring the safety and efficacy of hepatic arterial infusion chemotherapy and sequential transarterial embolization combined with lenvatinib and tislelizumab in unresectable hepatocellular carcinoma

被引：0
|
作者：
Zhong, Jian-Hong [1 ]
Chen, Zu-Shun [1 ]
Qi, Lu-Nan [1 ]
Zhang, Zhi-Ming [1 ]
Xiang, Bang-De [1 ]
Ma, Liang [1 ]
机构：
[1] Guangxi Med Univ Canc Hosp, Nanning, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16219
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Hepatic arterial infusion chemotherapy sequential transarterial embolization combined with lenvatinib and tislelizumab in patients with high-risk unresectable hepatocellular carcinoma: A phase II trial
    Zhong, J-H.
    Deng, Z.
    Qi, L-N.
    Chen, Z-S.
    Zhang, Z-M.
    Xiang, B.
    Ma, L.
    ANNALS OF ONCOLOGY, 2024, 35 : S1484 - S1484
  • [2] Hepatic arterial infusion chemotherapy (HAIC) combined with Tislelizumab and Lenvatinib for unresectable hepatocellular carcinoma: a retrospective single-arm study
    Sun, Ruirui
    Gou, Yang
    Pan, Long
    He, Qiang
    Zhou, Yin
    Luo, Yi
    Wu, Chenrui
    Zhao, Yaowu
    Fu, Zixuan
    Huang, Ping
    CELLULAR ONCOLOGY, 2024,
  • [3] Correction to: Hepatic arterial infusion chemotherapy (HAIC) combined with Tislelizumab and Lenvatinib for unresectable hepatocellular carcinoma: a retrospective single-arm study
    Ruirui Sun
    Yang Gou
    Long Pan
    Qiang He
    Yin Zhou
    Yi Luo
    Chenrui Wu
    Yaowu Zhao
    Zixuan Fu
    Ping Huang
    Cellular Oncology, 2024, 47 (6) : 2277 - 2278
  • [4] Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and tislelizumab for unresectable hepatocellular carcinoma: A single-arm, phase II study.
    Xu, Yongkang
    Fu, Shumin
    Mao, Ye
    Yi, Fengming
    Jiang, Weiming
    Feng, Long
    Wu, Jianbing
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 500 - 500
  • [5] Efficacy and safety of hepatic arterial infusion chemotherapy combined with transarterial embolization for unresectable hepatocellular carcinoma: A propensity score-matching cohort study
    Guo, Wenbo
    Gao, Jian
    Zhuang, Wenquan
    Wu, Zhiqiang
    Li, Bin
    Chen, Song
    JGH OPEN, 2020, 4 (03): : 477 - 483
  • [6] Comparative study on the efficacy and safety of transarterial chemoembolization combined with hepatic arterial infusion chemotherapy for large unresectable hepatocellular carcinoma
    Yang, Jing
    Shang, Xianfu
    Li, Junbiao
    Wei, Ning
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (01) : 346 - 355
  • [7] Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and sequential ablation in the treatment of advanced hepatocellular carcinoma
    Liu, Yulong
    Qiao, Yansong
    Zhou, Miaoli
    Guo, Jiandong
    Lin, Yinsheng
    Li, Wanghai
    An, Chao
    Li, Chengzhi
    CANCER MEDICINE, 2023, 12 (05): : 5436 - 5449
  • [8] Efficacy and safety of hepatic arterial infusion chemotherapy combined with donafenib in the treatment of unresectable hepatocellular carcinoma
    Wan, Tao
    Gan, Xueqin
    Xiong, Weijie
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 (06) : 747 - 753
  • [9] Hepatic arterial infusion chemotherapy for hepatocellular carcinoma resistant to transarterial embolization
    Sun, Wei-Chih
    Tsai, Wei-Lun
    Yu, Hsien-Chung
    Lai, Kwok-Hung
    Hsu, Ping-I
    Lin, Kung-Hung
    Chen, Wen-Chi
    Chan, Hoi-Hung
    Cheng, Jin-Shiung
    Liang, Huei-Lung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 356 - 357
  • [10] Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab with or Without Transhepatic Arterial Embolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and High Tumor Burden: A Multicenter Retrospective Study
    Chen, Song
    Shi, Feng
    Wu, Zhiqiang
    Wang, Liguang
    Cai, Hongjie
    Ma, Ping
    Zhou, Yuanmin
    Mai, Qicong
    Wang, Fan
    Tang, Shuangyan
    Zhuang, Wenquan
    Lai, Jiaming
    Chen, Xiaoming
    Chen, Huanwei
    Guo, Wenbo
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 1209 - 1222
12345